Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kersten

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Rheumatology (Oxford, England)|March 29, 2024
Efficacy of methylprednisolone in very early systemic sclerosis: results of the 'Hit Hard and Early' randomized controlled trialBrigit E Kersten, Jacqueline M J Lemmers, Amber Vanhaecke, et al.
Obesity Surgery|April 5, 2014
The impact of surgical complications as a main risk factor for venous thromboembolism: a multicenter studyF Celik, F Bounif, J M Fliers, et al.
European Journal of Internal Medicine|April 10, 2024
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature reviewA Dima, M C Vonk, A Garaiman, et al.
Science (New York, N.Y.)|May 15, 2012
Vesta's shape and morphologyR Jaumann, D A Williams, D L Buczkowski, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Rheumatology (Oxford, England)|March 29, 2024
Efficacy of methylprednisolone in very early systemic sclerosis: results of the 'Hit Hard and Early' randomized controlled trialBrigit E Kersten, Jacqueline M J Lemmers, Amber Vanhaecke, et al.
Obesity Surgery|April 5, 2014
The impact of surgical complications as a main risk factor for venous thromboembolism: a multicenter studyF Celik, F Bounif, J M Fliers, et al.
European Journal of Internal Medicine|April 10, 2024
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature reviewA Dima, M C Vonk, A Garaiman, et al.
Science (New York, N.Y.)|May 15, 2012
Vesta's shape and morphologyR Jaumann, D A Williams, D L Buczkowski, et al.
Pageof 7